Sysmex Europe
Menu

Please select your country. This will keep you up to date with your country-specific information.

Sentimag - Magseed in breast cancer

  • Small seed. Big impact.
  • Confidence meets convenience – for clinicians and patients
  • Sentimag® - One system, with multiple flexible applications
  • No wire. No radioactivity. Just magnetism.

Documents

All
  • All
  • Brochure
  • Literature
Documents

Sentimag / Magseed - Magnetic lesion and lymph node localisation

In recent years, advancements in medical practices have offered more women diagnosed with breast cancer the opportunity to receive breast-conserving and lymph node-sparing surgery. At any stage, the target is to de-escalate the surgical radicality.

To ensure both oncologic safety and patient comfort, reliable marking of lesions and target lymph nodes is a prerequisite. However, many tissue markers encounter significant challenges, including:

  • unreliable detectability due to migration or low visibility in imaging
  • radiation exposure
  • not always suitable for long-term placement
  • not always suitable for each tissue type

As a result, patients can experience discomfort, such as unnecessary anxiety, physical pain and a suboptimal cosmetic outcome.

The Magseed® marker has been specifically designed to overcome the challenges of other clip, reflector, tag, radioseed and wire markers. It enables a flexible patient treatment pathway – from placement of the marker until the day of surgery. Magseed® promotes high oncologic safety, accurate tissue localisations and improved patient satisfaction, preventing unnecessary surgery and helping to reduce the extent of the required ones.

Magseed® is used alongside the Sentimag® system, a sensitive magnetic detector that locates the seed. The marker is deployed under ultrasound or X-ray guidance any time before surgery. Once in the operating room, the surgeon then uses the Sentimag® system’s probe to precisely locate the Magseed®, and thereby the lesion or lymph node in which the Magseed® has been placed.

Magseed® – benefits for clinicians and patients

  • Designed with the patient in mind – no radioactivity, reduced stress, less pain
  • Placed in any soft tissue – breast lesion, lymph node, etc.
  • Can be implanted for as long as needed – always reliably detectable by Sentimag®
  • Smallest non-radioactive seed – ideal for lymph node placement
  • Decoupling of OR and radiology scheduling
  • Stays securely in place without migration from soft tissue
  • Very low re-excision rate for lesions (11 % averaged over multiple studies)
  • Magseed® has been used in over 50,000 tissue localisations
  • Sentimag® and Magseed® are CE-marked and FDA-cleared for soft tissue

 

Endomag®, Sentimag® and Magseed® are registered European Union trademarks of Endomagnetics Ltd www.endomag.com

Magtrace® is a registered trademark of Endomagnetics Ltd in the United Kingdom www.endomag.com

Lymph node localisation
(Sentimag - Magtrace)

Oncology

Does your system offer all of this

Does your system offer all of this

* Using Sentimag® in combination with Sienna+® magnetic tracer or using a gamma probe in combination with 99mTc tracer

Video: Magseed

Video: Magseed

Clinical results – radiologists

Clinical results – radiologists

*Hookwire, Radioactive Seed, SAVI Scout

Clinical results – surgeons

Clinical results – surgeons

Clinical results – radiologists & surgeons

Clinical results – radiologists & surgeons

X-ray visibility

X-ray visibility

Ultrasound visiblity

Ultrasound visiblity

Publication Spotlight - Targeted Axillary Dissection (TAD)

Publication Spotlight - Targeted Axillary Dissection (TAD)

Contact

Sysmex Europe GmbH

+49 (40) 527 26 0
+49 (40) 527 26 100
info@sysmex-europe.com
Bornbarch 1
22848 Norderstedt
Germany

Create Pdf

Workflow of OSNA RD-210

Watch video

Magseed placement in radiology

Watch the video

Lesion localisation with Magseed in surgery

Watch the video
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Find your job